Fractyl Health, Inc. Common Stock
Fractyl Health, Inc. Common Stock (GUTS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GUTS · as of Jun 9, 2026
Key Statistics
Explore Fractyl Health, Inc. Common Stock Data
guts stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
The GUTS analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +646.27% upside from the current price of $0.67.
Competitors & Peers
guts competitorsGUTS
ADVM
ALXO
ARTV
ATYR
BMEAStock Performance
Full HistoryAbout Fractyl Health, Inc. Common Stock
Fractyl Health, Inc. Common Stock Fractyl Health, Inc. is a biopharmaceutical firm dedicated to advancing treatments for type 2 diabetes (T2D) and obesity. Among its offerings is the Revita DMR System (Revita), an outpatient procedure…
what is fractyl health, inc. common stock · guts stock overview · fractyl health, inc. common stock company profile · who is fractyl health, inc. common stock ceo · guts NASDAQ · fractyl health, inc. common stock headquarters · fractyl health, inc. common stock business segments
About Stock Overview & Key Data
Fractyl Health, Inc. Common Stock (GUTS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 2, 2024. As of the latest trading session, GUTS stock price is $0.67, with a market capitalization of $48.4M. The stock has returned -76.74% over the past 12 months and -69.55% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Fractyl Health, Inc. Common Stock stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, Fractyl Health, Inc. Common Stock reported revenue of — and net income of -$141.0M. For detailed data — including Fractyl Health, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Fractyl Health, Inc. Common Stock (GUTS) stock price is $0.67. The stock is traded on NASDAQ under the ticker symbol GUTS. The 52-week range is $0.38 – $3.03.